Cargando…
Author Correction: Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
Autores principales: | Hildebrandt, Susanne, Baschant, Ulrike, Thiele, Sylvia, Tuckermann, Jan, Hofbauer, Lorenz C., Rauner, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271193/ https://www.ncbi.nlm.nih.gov/pubmed/32494045 http://dx.doi.org/10.1038/s41598-020-65962-6 |
Ejemplares similares
-
Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
por: Hildebrandt, Susanne, et al.
Publicado: (2018) -
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
por: Gado, Manuel, et al.
Publicado: (2022) -
Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway
por: Balaian, Ekaterina, et al.
Publicado: (2018) -
Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
por: Thiele, Sylvia, et al.
Publicado: (2019) -
Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss
por: Lehmann, Juliane, et al.
Publicado: (2021)